NO20063715L - Syntese av spongosin - Google Patents

Syntese av spongosin

Info

Publication number: NO20063715L
Authority: NO; Norway
Prior art keywords: synthesis; spongosine; methoxyadenine; benzoyl; tri
Prior art date: 2004-01-21

Application number

NO20063715A

Other languages

English (en)

Norwegian (no)

Inventor

Jacqueline Valerie Anne Ouzman

Original Assignee

Cambridge Biotechnology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-21

Filing date

2006-08-18

Publication date

2006-08-18

2006-08-18 Application filed by Cambridge Biotechnology Ltd filed Critical Cambridge Biotechnology Ltd

2006-08-18 Publication of NO20063715L publication Critical patent/NO20063715L/no

Links

AJACDNCVEGIBNA-KQYNXXCUSA-N (2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C12=NC(OC)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O AJACDNCVEGIBNA-KQYNXXCUSA-N 0.000 title abstract 3
AJACDNCVEGIBNA-UHFFFAOYSA-N 2-Methoxyadenosine Natural products C12=NC(OC)=NC(N)=C2N=CN1C1OC(CO)C(O)C1O AJACDNCVEGIBNA-UHFFFAOYSA-N 0.000 title abstract 3
230000015572 biosynthetic process Effects 0.000 title abstract 3
238000003786 synthesis reaction Methods 0.000 title abstract 3
NZRGFQAPUIYXEP-ZYWWQZICSA-N [(2r,3r,4r,5r)-5-(6-amino-2-methoxypurin-9-yl)-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1OC(=O)C=1C=CC=CC=1)OC(=O)C=1C=CC=CC=1)N1C=NC2=C(N)N=C(N=C21)OC)OC(=O)C1=CC=CC=C1 NZRGFQAPUIYXEP-ZYWWQZICSA-N 0.000 abstract 2
TUDKBZAMOFJOSO-UHFFFAOYSA-N 2-methoxy-7h-purin-6-amine Chemical compound COC1=NC(N)=C2NC=NC2=N1 TUDKBZAMOFJOSO-UHFFFAOYSA-N 0.000 abstract 1
GCZABPLTDYVJMP-CBUXHAPBSA-N [(2r,3r,4r,5s)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1OC(=O)C=1C=CC=CC=1)OC(=O)C=1C=CC=CC=1)OC(=O)C)OC(=O)C1=CC=CC=C1 GCZABPLTDYVJMP-CBUXHAPBSA-N 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
238000010511 deprotection reaction Methods 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Saccharide Compounds (AREA)
Silicon Polymers (AREA)
Catalysts (AREA)

NO20063715A 2004-01-21 2006-08-18 Syntese av spongosin NO20063715L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0401292.8A GB0401292D0 (en)	2004-01-21	2004-01-21	Synthesis of spongosine
PCT/GB2005/000183 WO2005070947A1 (en)	2004-01-21	2005-01-19	Synthesis of spongosine

Publications (1)

Publication Number	Publication Date
NO20063715L true NO20063715L (no)	2006-08-18

Family

ID=31971211

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063715A NO20063715L (no)	2004-01-21	2006-08-18	Syntese av spongosin

Country Status (18)

Country	Link
US (1)	US20100216991A1 (pl)
EP (1)	EP1709057B1 (pl)
JP (1)	JP2007518782A (pl)
KR (1)	KR20060132910A (pl)
CN (1)	CN1910194B (pl)
AT (1)	ATE381572T1 (pl)
AU (1)	AU2005206361A1 (pl)
CA (1)	CA2552552A1 (pl)
CY (1)	CY1108048T1 (pl)
DE (1)	DE602005003922T2 (pl)
DK (1)	DK1709057T3 (pl)
ES (1)	ES2298998T3 (pl)
GB (1)	GB0401292D0 (pl)
NO (1)	NO20063715L (pl)
NZ (1)	NZ548220A (pl)
PL (1)	PL1709057T3 (pl)
PT (1)	PT1709057E (pl)
WO (1)	WO2005070947A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080221060A1 (en) *	2004-03-05	2008-09-11	Martyn Pritchard	Therapeutic Compounds
WO2014068589A2 (en) *	2012-10-29	2014-05-08	Biophore India Pharmaceuticals Pvt. Ltd.	Novel process for the preparation of (1-{9-[(4s, 2r, 3r, 5r)-3, 4-dihydroxy-5-(hydroxymethyl) oxolan-2-yl)-6-aminopurin-2-yl} pyrazole-4-yl)-n-methylcarboxamide
CN103342727A (zh) *	2013-07-01	2013-10-09	淮海工学院	一种2-甲氧基腺苷的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030008841A1 (en) *	2000-08-30	2003-01-09	Rene Devos	Anti-HCV nucleoside derivatives

2004
- 2004-01-21 GB GBGB0401292.8A patent/GB0401292D0/en not_active Ceased
2005
- 2005-01-19 ES ES05701948T patent/ES2298998T3/es not_active Expired - Lifetime
- 2005-01-19 NZ NZ548220A patent/NZ548220A/en unknown
- 2005-01-19 CN CN200580003003XA patent/CN1910194B/zh not_active Expired - Fee Related
- 2005-01-19 DK DK05701948T patent/DK1709057T3/da active
- 2005-01-19 AT AT05701948T patent/ATE381572T1/de active
- 2005-01-19 JP JP2006550274A patent/JP2007518782A/ja active Pending
- 2005-01-19 WO PCT/GB2005/000183 patent/WO2005070947A1/en not_active Ceased
- 2005-01-19 PT PT05701948T patent/PT1709057E/pt unknown
- 2005-01-19 CA CA002552552A patent/CA2552552A1/en not_active Abandoned
- 2005-01-19 AU AU2005206361A patent/AU2005206361A1/en not_active Abandoned
- 2005-01-19 US US10/586,558 patent/US20100216991A1/en not_active Abandoned
- 2005-01-19 DE DE602005003922T patent/DE602005003922T2/de not_active Expired - Lifetime
- 2005-01-19 PL PL05701948T patent/PL1709057T3/pl unknown
- 2005-01-19 KR KR1020067016484A patent/KR20060132910A/ko not_active Ceased
- 2005-01-19 EP EP05701948A patent/EP1709057B1/en not_active Expired - Lifetime
2006
- 2006-08-18 NO NO20063715A patent/NO20063715L/no not_active Application Discontinuation
2008
- 2008-03-07 CY CY20081100268T patent/CY1108048T1/el unknown

Also Published As

Publication number	Publication date
EP1709057A1 (en)	2006-10-11
WO2005070947A1 (en)	2005-08-04
CA2552552A1 (en)	2005-08-04
GB0401292D0 (en)	2004-02-25
JP2007518782A (ja)	2007-07-12
CN1910194A (zh)	2007-02-07
NZ548220A (en)	2009-12-24
HK1099026A1 (zh)	2007-08-03
PL1709057T3 (pl)	2008-05-30
DE602005003922T2 (de)	2008-12-04
DK1709057T3 (da)	2008-04-28
EP1709057B1 (en)	2007-12-19
DE602005003922D1 (de)	2008-01-31
AU2005206361A1 (en)	2005-08-04
PT1709057E (pt)	2008-03-10
KR20060132910A (ko)	2006-12-22
ES2298998T3 (es)	2008-05-16
US20100216991A1 (en)	2010-08-26
CN1910194B (zh)	2010-05-05
ATE381572T1 (de)	2008-01-15
CY1108048T1 (el)	2013-09-04

Similar Documents

Publication	Publication Date	Title
MX2007014132A (es)	2008-04-09	Compuestos de diarilhidantoina.
NO20080129L (no)	2008-01-08	Fremgangsmate for fremstilling av dihydrokinazoliner
CY1116768T1 (el)	2017-03-15	Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
EP1732602A4 (en)	2008-05-07	CYTOTOXICITY TRANSFER OF CELLS WITH NOTES ON SURFACE EXPRESSION OF MCSP
ECSP056111A (es)	2006-03-01	Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
ATE524476T1 (de)	2011-09-15	Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
TW200637614A (en)	2006-11-01	Bendamustine pharmaceutical compositions
ECSP088221A (es)	2008-03-26	Agonistas adrenoreceptores alfa2c
UA85559C2 (en)	2009-02-10	Aminobenzophenone compounds
CL2007000789A1 (es)	2008-01-18	Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
SE0301653D0 (sv)	2003-06-05	Novel compounds
BRPI0508700A (pt)	2007-08-07	uso de sns-595, composição farmacêutica, e, pó liofilizado
UA102858C2 (ru)	2013-08-27	Производные пиридино-пиридинонов, способ их получения и применения в терапии
EA200601822A1 (ru)	2007-02-27	Способы получения полиморфной формы i гидросульфата клопидогрела
EA200700717A1 (ru)	2007-10-26	Сульфонамиды
CO5660287A2 (es)	2006-07-31	Derivados de tetrahidrocarbazol y su uso farmaceutico
EP1667716B8 (en)	2012-03-28	Cytotoxicity mediation of cells evidencing surface expression of cd44
CY1108156T1 (el)	2014-02-12	Στερεοεκλεκτικη συνθεση αναλογων βιταμινης d
DE602006009789D1 (de)	2009-11-26	Acetylenderivate
CY1108048T1 (el)	2013-09-04	Συνθεση σπογγοσινης
MX2007011493A (es)	2008-04-14	Modalidades antiinflamatorias.
HRP20090513T1 (hr)	2009-10-31	S-mirtazapin, namijenjen liječenju napadaja vrućine
TW200716564A (en)	2007-05-01	Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200621703A (en)	2006-07-01	Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TWD124042S1 (zh)	2008-08-01	計算機

Legal Events

Date	Code	Title	Description
2011-09-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application